Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress

MELBOURNE, Australia and SAN FRANCISCO, Dec. 04, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, will...

Related Keywords

Australia ,California ,United States ,Sydney ,New South Wales ,Melbourne ,Victoria ,San Francisco ,Remy Bernarda ,Hannah Howlett ,David Stamler ,Nasdaq ,Alterity Therapeutics ,Multiple System ,Media Contacts ,Markets ,